ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year
across USA, Europe & Asia with support from 1000 more scientific Societies and
Publishes 700+ Open Access Journals which contains over 50000
eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other
Subscription Journals (Source: Google Analytics)
 
 
 
Jagat R Kanwar
Jagat R Kanwar

Jagat R Kanwar, PhD
Associate Professor
Immunology and Molecular Biomedical Research Institute
for Technology Research & Innovation
Deakin University
Australia
Tel. 006-135-227-1148

Biography

Jagat R Kanwar is an immunologist and molecular biochemist with an international reputation in investigating fundamental and applied molecular aspects of cancer and chronic inflammation. He did his PhD from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Before joining Deakin University in 2006, he was a Senior Scientist/Senior Research Fellow in the University of Auckland, Auckland, New Zealand. During the past decade his research both academic and commercial has centered on understanding the pathophysiological mechanisms and/or finding treatments for a variety of chronic inflammatory diseases and different types of cancer. Dr. Kanwar has published 55 research articles, 12 invited reviews and 5 book chapters, in highly ranked, international, peer-reviewed journals. These publications have added to the body of knowledge in the fields of immunology, cancer gene therapy, nanomedicine, cell biology and biotechnology, and have extended these disciplines. He is a key inventor on 9 international patents and has provided consultancy to 5 Biotechnology based companies. He is a member of editorial board for 7 international journals and a nominated member of more than 12 national and international societies including American Society of Nanomedicine. He has extensive and close collaborations with colleagues from New Zealand, Australia, Singapore, India, China and USA.

Research Interest

Nanotechnology based drug delivery of proteins/peptides, siRNA and miRNA to target cancer and chronic inflammation drug discovery for novel anticancer targets for cancer cell survival, death, arrest, and repair development of immunomodulatory and anti-inflammatory bioactives, proteins and peptides for neuroprotection development of complementary alternative medicine from the milk derived proteins including metal binding protein (Lactoferrin), and herbal preparation derived active components with a special focus on the treatment of solid tumours (colon and breast cancers).

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Curcumin Regulates Colon Cancer by Inhibiting P-Glycoprotein in In-situ Cancerous Colon Perfusion Rat Model

Prasad Neerati, Yakkanti A. Sudhakar and Jagat R Kanwar

Research Article: J Cancer Sci Ther/Vol.5.9 313-319(2013)
doi: 10.4172/1948-5956.1000221
 
Survivin in Cancer: A Spider in the Web

Sishir K Kamalapuram, Rupinder K Kanwar and Jagat R Kanwar

Editorial: J Nanomed Nanotechnol 2012, 3:e118
doi: 10.4172/2157-7439.1000e118
 
Multifunctional Nanotherapeutics: ?The Engines of Healing?

Jagat R Kanwar

Editorial: J Cancer Sci Ther/Vol.4.12 xxiii-xxiv (2012)
doi: 10.4172/1948-5956.1000e115
 
Multifunctional Nanotheranostics: Do We Really Need Them?

Jagat R Kanwar

Editorial: J Cancer Sci Ther/Vol.4.11 xxii-xxii (2012)
doi: 10.4172/1948-5956.1000e114
 
Natural Therapeutics Targeting Survivin

Jagat R Kanwar, Rasika M Samarasingie and Rupinder K Kanwar

Editorial: Biochem Anal Biochem 2012, 1: e121
doi: 10.4172/2161-1009.1000e121
 
Influence of Curcumin on Pioglitazone Metabolism and Pk/Pd: Diabetes Mellitus

Prasad Neerati, Ravi Karan M and Jagat R Kanwar

Research Article: J Diabetes Metab 2012, S6-003
doi: 10.4172/2155-6156.S6-003
 

türk porno izletürk pornoları doyasıya izleyin ve boşalın.

 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version